Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences.

Slides:



Advertisements
Similar presentations
Strategies to strengthen the distribution system to improve the availability of medicine Dr Wael Inmair Director Assistant, Central Medical Supply Store,
Advertisements

Strengthening the Pharmaceutical Sector: Mechanisms to Monitor Performance Douglas L. Keene June 15, 2010.
Vertical versus Decentralized TB Pharmaceutical Management
Healthcare Waste Management Programme
Rational Use of Injections within National Drug Policies World health organisation Essential Drugs and Medicines Policy Safe Injection Global Network Cairo.
KINGDOM OF CAMBODIA Ministry of Health National Center for Parasitology, Entomology and Malaria Control CNM.
Management of Medicines and Pharmaceutical Supplies for use in the prevention and treatment of Pre-eclampsia and Eclampsia Grace Adeya, SPS/MSH February.
Antibiotic Policy in Ghana; the way forward
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Supply Chains Management for Pharmacy
Unit 8 Supply Chain. Objectives 1.Describe the special nature of health care commodities due to the need for provider advice and counseling 2.Describe.
The Drug Management Cycle – Distribution
Management of the Tuberculosis Drug Supply Module 13 – March 2010.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
Role of Pharmacist in Malaria Control
World Health Organization
046:127 Pharmaceutical Management for Underserved Populations  Paper on Current Controversy  Team Assignment: Observational Visits  National Drug Policy/Assessment.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
Using Longitudinal Data for Evaluating Policy Changes and Other Interventions -Information system in Tamilnadu Medical Services Corporation.
Wilbert Bannenberg SARPAM
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
“The causes of Anti-TB medicines shortages in EMR countries and how to avoid them in the future” Khaled Sultan Drug Management Technical Officer, STOP.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
ASSESSMENT OF AVAILABILITY, PRICE AND AFFORDABILITY OF MEDICINES FOR CHILDREN IN GHANA Authors: Gyansa-Lutterodt M. 1,Andrews Annan E. 2, Koduah A. 1,
The Pharmaceutical Situational Analysis in Mongolia 1 Chimedtseren Munkhdelger 1 Sanjjav Tsetsegmaa 2, 1 Ministry of Health, 2 Pharmacy School, Health.
Tanzania1. 2 Tanzania Assessment Gabriel Upunda Tanzania3 DemographicsTanzania Area (sq km)945,100 Population 32,900,000 25% urban GNP per capitaUS $240.
OVERVIEW OF THE ZIMBABWE NATIONAL MEDICINES POLICY Dr C E Ndhlovu, M Med Sci, FRCP Chairperson, NMTPAC Deputy Dean, UZCHS National workshop, Jan 22-23,
Good Procurement Practices in National TB Programs
Paula Munderi Department of Essential Drugs and Medicines Policy World Health Organization Access to essential medicines for HIV/AIDS - update on WHO activities.
1 Oct 2005 WHO/STB/THD World Health Organization 4 th Meeting of Subgroup on laboratory capacity strengthening Paris, France, October Ernesto Jaramillo.
ACCESS TO MEDICINES - POLICY AND ISSUES
Lucile de Comarmond Chief Pharmacist Workshop on Impact of TRIPS/IP on Access to Medicine September 2014.
CPM Programs1. 2 Center for Pharmaceutical Management Programs James Rankin.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
CO “All-Ukrainian Network of People Living with HIV” Potential Problems in Supply – What Can Be Done? Kyiv, 2008.
Yemaneberhan Taddesse.  PASDEP(plan of accelerated and sustainable development for the Eradication of poverty) Poverty reduction strategy is the main.
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
From 3by5 to Universal Access to HIV/AIDS Treatment: AMDS Technical Briefing Seminar for Consultants on Procurement and Supply Management for HIV, TB and.
1 Pharmaceutical System Strengthening: Is There a Need for a New Paradigm? Douglas Keene, PharmD, MHS ICIUM-3 Pre-Conference Session 14 November 2011.
Securing the Supply of Condoms and Other Essential Products for HIV/AIDS Programs Tony Hudgins Yasmin Chandani John Snow Research & Training Institute.
TBS 2008-H. Tata & M. Babaley Mapping and In-depth Assessment of Medicines Procurement and Supply Systems WHO Technical Briefing Seminar 17 th -21 st November.
Quantification from a TB Perspective PSM Workshop to Develop GFATM PSM plans for HIV, TB and Malaria February 2006, Nairobi.
Mobilizing Single Practice Providers for DOTS Network Service Delivery Marilou P. Costello, PhD Elmer S. Soriano, MD Philippine Tuberculosis Initiative.
Lesotho UHC Meeting Cape Town. Take Home Points HR Infrastructure Technology and information for decision making Supply chain Governance – Cooperate.
Drug Management of Second-line anti-TB drugs through the Green Light Committee mechanism for programmes funded by the Global Fund to Fight Against AIDS,
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
ADDRESSING PHARMACEUTICAL SUPPLY CHAIN NEEDS PRESENTATION TO HEALTH DONOR GROUP MEETING 8 July 2009.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
Treatment Regimens for Pulmonary Tuberculosis Caused by Drug- Susceptible Organisms Initial PhaseContinuation Phase RegimenDrugs Interval and Doses (Minimal.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Zambia’s Country Experiences
QUALITY ASSURANCE OF PHARMACEUTICAL PRODUCTS IN RMH
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
Richard Laing EMP/WHO TBS 2012
1 Results Background RSBY – What is the Scheme?
Richard Laing, Kelly McGoldrick
Impact of Using Fixed Dose Combinations (FDCs) versus
Access to HIV/AIDS Medicines The 3x5 strategy
Managerial and Regulatory Strategies to Improve Drug Use
National Medicines Policies
Managerial and Regulatory Strategies to Improve Drug Use
Richard Laing WHO/PAU TBS 2013
Access to Essential Medicines
Title : Quality data for efficient management - lessons from the UNRWA Health Procurement Strengthening Project   Abstract: Introduction :UNRWA has been.
Pharmacy Sector SECTOR COMMITMENT TO END TB
Hospital pharmacy.
National Medicines Policies
Strategies to Improve Drug Use
Presentation transcript:

Introduction to Elements of In-Country Drug Management with Focus on TB Drugs Jim Rankin Director, Center for Pharmaceutical Management Management Sciences for Health

 Government commitment  Case detection by sputum smear microscopy  Standardized treatment regimen  Regular uninterrupted supply of essential TB drugs  Standardized recording and reporting system Five Elements of DOTS

Supply Management Cycle Selection Procurement Management Support Distribution Use Policy and Legal Framework

 National tuberculosis program  Drug policy and legislation  Product registration/licensing  Product quality assurance policies and regulations  Procurement policy  Policies on use of drugs by health providers and consumers

Selection of TB Drugs  Morbidity, resistance patterns, utilization factors, Stop TB guidelines  Standard treatments for country  First-line drugs: INH, rifampicin, ethambutol, pyrazinamide, streptomycin  Second-line drugs: capreomycin, cycloserine, aminoglycosides, quinolones  Limited list  Fixed-dose combinations versus individual products  Packaging for optimal use

Procurement  Follow good procurement practices  Base on accurate quantification  Secure funding to meet needs  Compare potential sources of supply  Choose appropriate procurement method  Select appropriate suppliers  Assure drug quality  Monitor supplier performance

Distribution (Supply Chain Management)  Develop plan to ensure effective/efficient supply chain  Ensure efficient clearance, storage, transport, stock control  Provide qualified staff to manage and operate system  Use effective management information systems  Monitor performance at all levels  Consider public, NGO, and private-sector options

Public-Private Supply Systems

International Manufacturers International Procurement Agencies LEVELS PRIVATE SECTOR PUBLIC SECTOR National Local Manufacturers Regional Local Wholesalers Regions Medical Stores, Hospitals District Districts Medical Stores Hospitals Health Centers Shops, Pharmacies Community Health Workers Government/NGOSupply Services Central Level Procurement Unit Finance Unit Medical Stores Importer-Wholesalers Consumers Key Drug flow in formal system Alternative drug flow (planned or unplanned) Typical Structure of Public-Private Dug Distribution

Rational Use (public or private)  DOTs system for administering drugs  Prescriber/dispenser/observer training  Monitor prescribing and DOTs  Patient and community education  Incentives/enablers for providers and patients

Management Support  Political/senior manager commitment  Effective planning  Effective implementation and management  Effective management information systems  Monitoring and evaluation  Constant vigilance to ensure continuous, unbroken cycle